CAC 40
6 986,25 -10,80 (-0,15 %) Euro Stoxx 50
4 085,35 -10,24 (-0,25 %) Dow Jones
33 002,38 -430,97 (-1,29 %) EUR/USD
1,0488 +0,0019 (+0,18 %) Gold future
1 837,90 -3,60 (-0,20 %) Bitcoin EUR
26 178,53 -89,57 (-0,34 %)
Siemens Healthineers AG (SHL.DE)
Siemens Healthineers AG
Henkestrasse 127
Erlangen 91052
Germany
49 9131 84 3385
https://www.siemens-healthineers.com
Secteur(s): Healthcare
Secteur d’activité: Medical Devices
Employés à temps plein: 70 800
Dirigeants clés
| Nom | Titre | Payer | Exercé | Année de naissance |
|---|---|---|---|---|
| Dr. Bernhard Montag | Pres, CEO & Chairman of Management Board | 3,23M | S.O. | 1969 |
| Dr. Jochen Schmitz Ph.D. | CFO & Member of Management Board | 1,91M | S.O. | 1966 |
| Ms. Darleen Caron | Chief HR Officer, Labor Director & Member of Management Board | 1,61M | S.O. | 1964 |
| Ms. Elisabeth Staudinger-Leibrecht | Member of Management Board | 1,15M | S.O. | 1970 |
| Mr. Peter Koerte Ph.D. | Chief Technology & Strategy Officer | S.O. | S.O. | S.O. |
| Mr. Marc Koebernick | Head of Investor Relations | S.O. | S.O. | S.O. |
| Christian Klaussner | Exec. VP of Fin. | S.O. | S.O. | S.O. |
| Andre Hartung | Head of Imaging | S.O. | S.O. | S.O. |
| Carsten Bertram | Head of Advanced Therapies | S.O. | S.O. | S.O. |
| Bernd Ohnesorge | Head of Europe, Middle East & Africa | S.O. | S.O. | S.O. |
Description
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems. The Diagnostics segment offers in-vitro diagnostic products and services to healthcare providers in laboratory, molecular, and point-of-care diagnostics; and workflow solutions for laboratories and informatics products. The Varian segment provides cancer care technologies, and solutions and services to oncology departments in hospitals and clinics; and technology-enabled optimized workflows, clinical services and consulting capabilities, and digital solutions and applications for managing treatment and therapy. The Advanced Therapies segment offers products that are designed to support image-guided minimally invasive treatments in various areas, such as cardiology, interventional radiology, and surgery; and angiography systems and mobile C-arms, including a robotic-assisted platform for endovascular coronary and peripheral vascular interventions. It also provides equipment performance management, clinical education and e-learning, asset management, and managed departmental services for laboratories and healthcare facilities, as well as consulting and digital health services. Siemens Healthineers AG has a collaboration with Oncimmune Holdings plc. The company is headquartered in Erlangen, Germany. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft.
Gouvernance d’entreprise
L’ISS Governance QualityScore de Siemens Healthineers AG en date du 1 octobre 2023 est 4. Les scores principaux sont Audit : 2; Société : 6; Droits des actionnaires : 6; Compensation : 1.
